LM

Leslie Mi Ok Chong

Imugene Limited | Chief Executive Officer, Managing Director
Ms Chong joined the Group from the leading oncology clinical development company, Genentech (a member of the Roche family), where she was a Senior Clinical Program Lead at the head office in San Francisco. She has over 25 years of experience in leading clinical and department development in oncology. In November 2016, Former directorships in last three years - Cure Brain Cancer Foundation (non-profit organisation), until 11 April 2023.

Company and Roles

Company
Title
Tenure
Since
IMU
Imugene Limited
  • Chief Executive Officer
  • Managing Director
8yrs, 2mthNov 2016

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
IMU
Imugene Limited
01/07/2485,710,4161,500,00023,216,666N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
IMU
Imugene Limited
01/07/24
Transfer
1,500,000$0.055$82,500As advised by the company
IMU
Imugene Limited
01/07/24
Buy
5,793,750$0.055$318,656Conversion of securities
IMU
Imugene Limited
01/07/24
Transfer
1,500,000$0.055$82,500As advised by the company
IMU
Imugene Limited
01/07/24
Exercise
5,793,750$0.055$318,656Conversion of securities
IMU
Imugene Limited
12/01/24
Issued
23,175,000$0.120$2,781,000Issue of securities